Threads / National Cancer Plan for England / To ask the Secretary of State for Health and Social Care, w…
Written Question Published 28 Apr 2026 Department of Health and Social Care ↗ View on Parliament

To ask the Secretary of State for Health and Social Care, what assessment he has made of the clinical and cost effectiveness of first-line use of encorafenib in combination with cetuximab and chemotherapy for patients with BRAF V600E-mutant metastatic col

To ask the Secretary of State for Health and Social Care, what assessment he has made of the clinical and cost effectiveness of first-line use of encorafenib in combination with cetuximab and chemotherapy for patients with BRAF V600E-mutant metastatic col